<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 23.2: Microbiota Restoration Therapy (MRT) & Next-Generation Probiotics</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Table Style */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f1f8f1;
            color: #059669;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #059669;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: Advanced Techniques (Level 2)</p>
            <h1 class="lesson-title">Lesson 2: Microbiota Restoration Therapy (MRT) & Next-Generation Probiotics</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">L2 Expert Content</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Evolution of MRT & FMT</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Clinical Indications for FMT</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Next-Generation Probiotics (NGPs)</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Engineering Microbial Consortia</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Postbiotics & Metabolite Therapy</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Legal & Ethical Boundaries</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Evaluate the clinical efficacy and safety protocols of Fecal Microbiota Transplantation (FMT) for recurrent <i>C. diff</i> and beyond.</li>
                <li>Identify the therapeutic mechanisms of keystone Next-Generation Probiotics (NGPs) like <i>Akkermansia muciniphila</i>.</li>
                <li>Understand the shift from single-strain supplementation to engineered microbial consortia for complex dysbiosis.</li>
                <li>Analyze the clinical utility of postbiotics for sensitive or immunocompromised client populations.</li>
                <li>Define the coach's scope of practice regarding experimental microbial therapies and referral pathways.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Evolution of MRT & FMT</h2>
        <p>In the previous lesson, we explored how <span class="highlight">Precision Metagenomic Sequencing</span> allows us to map the gut landscape with unprecedented accuracy. However, mapping is only the first step; <strong>Microbiota Restoration Therapy (MRT)</strong> represents the intervention phase where we seek to rebuild a collapsed ecosystem. At the pinnacle of MRT stands Fecal Microbiota Transplantation (FMT).</p>

        <p>FMT involves the transfer of screened, healthy donor stool into the gastrointestinal tract of a recipient to restore microbial diversity. While the concept dates back to 4th-century China ("yellow soup"), modern medicine has refined it into a highly regulated procedure. The goal is no longer just "adding bacteria," but <span class="highlight">ecosystem transplantation</span>â€”reintroducing the complex web of bacteria, phages, fungi, and metabolites required for homeostasis.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">92%</div>
                    <div class="stat-label">C. diff Cure Rate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">450+</div>
                    <div class="stat-label">Active FMT Trials</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">1,000+</div>
                    <div class="stat-label">Species Transferred</div>
                </div>
            </div>
        </div>

        <h2 id="section2">2. Clinical Indications & Safety Protocols</h2>
        <p>Currently, the only FDA-enforced indication for FMT is <span class="highlight">recurrent Clostridioides difficile infection (rCDI)</span> that has failed standard antibiotic therapy. In this context, FMT is remarkably effective, often resolving infections within 24â€“48 hours that have persisted for months.</p>

        <h3>Emerging Research Areas</h3>
        <p>Beyond <i>C. diff</i>, researchers are investigating MRT for:</p>
        <ul>
            <li><strong>Inflammatory Bowel Disease (IBD):</strong> Specifically Ulcerative Colitis, where multi-donor "super-stool" has shown promise in inducing clinical remission.</li>
            <li><strong>Metabolic Syndrome:</strong> Transfers from lean donors to recipients with metabolic syndrome have shown transient improvements in insulin sensitivity (Vrieze et al., 2012).</li>
            <li><strong>Neuropsychiatric Conditions:</strong> Early trials in Autism Spectrum Disorder (ASD) have demonstrated sustained improvements in both GI symptoms and behavioral markers.</li>
        </ul>

        <div class="alert-box warning">
            <p class="alert-label">Critical Safety Note</p>
            <p>FMT is not without risk. In 2019, the FDA issued a safety alert following the death of a patient from an ESBL-producing <i>E. coli</i> transferred via FMT. This underscores why "DIY FMT" is strictly prohibited and dangerous. Professional donor screening now includes rigorous testing for multi-drug resistant organisms (MDROs) and viral pathogens like SARS-CoV-2.</p>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: Refractory Dysbiosis</p>
                    <p class="subtitle">Clinical Application of MRT</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">ðŸ‘¤</div>
                    <div class="patient-info">
                        <h4>Marcus S., 44</h4>
                        <p>Recurrent C. diff (3 bouts in 6 months) following spinal surgery antibiotics.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Marcus presented with chronic watery diarrhea (10+ times/day), significant weight loss, and severe "brain fog." Metronidazole and Vancomycin provided only temporary relief.</p>
                <p><strong>Intervention:</strong> Marcus underwent a colonoscopic FMT using a donor bank (OpenBiome) screened sample. Within 72 hours, bowel frequency dropped to 2 times/day. Metagenomic testing 4 weeks post-FMT showed a 400% increase in alpha-diversity.</p>
                <p><strong>Outcome:</strong> Complete resolution of CDI. Marcus worked with a Gut Health Coach post-FMT to implement a "microbiome-maintenance diet" high in diverse fibers to ensure the new ecosystem remained stable.</p>
            </div>
        </div>

        <h2 id="section3">3. Next-Generation Probiotics (NGPs)</h2>
        <p>The "First Generation" of probiotics (Lactobacillus and Bifidobacterium) were largely chosen because they were easy to grow and safe (GRAS). However, they are often transient and do not colonize the adult gut effectively. <span class="highlight">Next-Generation Probiotics (NGPs)</span> are commensal bacteria identified through metagenomic research as "keystone species" that play fundamental roles in human health.</p>

        <h3>Akkermansia muciniphila: The Mucus Sentinel</h3>
        <p><i>Akkermansia</i> accounts for 1â€“5% of the healthy human gut microbiome. It lives in the mucus layer, "grazing" on mucin and stimulating the host to produce more. This creates a feedback loop that strengthens the intestinal barrier.</p>
        <ul>
            <li><strong>Metabolic Impact:</strong> Low levels are consistently associated with obesity, Type 2 diabetes, and NAFLD.</li>
            <li><strong>Mechanism:</strong> It produces the protein <i>Amuc_1100</i>, which interacts with Toll-like receptor 2 (TLR2) to improve gut barrier function and reduce metabolic endotoxemia (LPS leakage).</li>
        </ul>

        <h3>Faecalibacterium prausnitzii: The Butyrate Factory</h3>
        <p>One of the most abundant bacteria in the healthy colon, <i>F. prausnitzii</i> is highly sensitive to oxygen (obligate anaerobe), making it difficult to manufacture. It is the primary producer of <span class="highlight">butyrate</span>, which provides energy to colonocytes and exerts systemic anti-inflammatory effects.</p>

        <h2 id="section4">4. Engineering Microbial Consortia</h2>
        <p>The future of MRT is moving away from the "black box" of whole stool toward <strong>Defined Microbial Consortia</strong>. Instead of thousands of unknown species, researchers are engineering groups of 10â€“15 specific strains that work synergistically.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Standard Probiotics</th>
                        <th>FMT (Whole Stool)</th>
                        <th>Next-Gen Consortia</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Composition</strong></td>
                        <td>1-10 transient strains</td>
                        <td>1000+ unknown strains</td>
                        <td>8-20 defined commensals</td>
                    </tr>
                    <tr>
                        <td><strong>Colonization</strong></td>
                        <td>Very Low</td>
                        <td>High</td>
                        <td>High/Targeted</td>
                    </tr>
                    <tr>
                        <td><strong>Safety</strong></td>
                        <td>Excellent</td>
                        <td>Variable (Pathogen risk)</td>
                        <td>High (Controlled)</td>
                    </tr>
                    <tr>
                        <td><strong>Mechanism</strong></td>
                        <td>General Immune Support</td>
                        <td>Ecosystem Replacement</td>
                        <td>Targeted Metabolic Fix</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">5. Postbiotics: The Safe Alternative</h2>
        <p>For clients with severe intestinal permeability ("leaky gut") or compromised immune systems, introducing live bacteria (even "good" ones) carries a risk of translocation into the bloodstream. This is where <span class="highlight">Postbiotics</span> become essential.</p>
        <p>Defined by ISAPP as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host," postbiotics include:</p>
        <ul>
            <li><strong>Heat-killed microbes:</strong> Which still possess cell-wall components that stimulate the immune system.</li>
            <li><strong>Short-Chain Fatty Acids (SCFAs):</strong> Direct supplementation of butyrate or acetate.</li>
            <li><strong>Exopolysaccharides:</strong> Carbohydrates secreted by bacteria that modulate the mucus layer.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">Coach's Application</p>
            <p>When working with a "highly sensitive" client who reacts to every probiotic, switching to a postbiotic (like heat-killed <i>L. acidophilus</i> or tributyrin) can often provide the benefits of microbial signaling without the risk of overgrowth or histamine reactions.</p>
        </div>

        <h2 id="section6">6. Legal & Ethical Boundaries for Coaches</h2>
        <p>As a Level 2 Gut Health Coach, you will encounter clients asking about FMT or experimental NGPs. Navigating this requires strict adherence to your <span class="highlight">Scope of Practice</span>.</p>
        
        <div class="principle-card">
            <div class="principle-title">The "Refer, Don't Recommend" Rule</div>
            <div class="principle-text">
                Coaches must never recommend or facilitate "DIY FMT." This is a medical procedure. Your role is to:
                <ul>
                    <li>Educate the client on the science behind these therapies.</li>
                    <li>Help the client prepare their "soil" (dietary diversity) if they are undergoing medical MRT.</li>
                    <li>Provide post-procedural support to ensure the newly introduced microbes have the prebiotic fuel to survive.</li>
                </ul>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is <i>Akkermansia muciniphila</i> considered a "Next-Generation Probiotic" compared to a standard <i>Lactobacillus</i> strain?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">Unlike standard probiotics which are often transient, Akkermansia is a commensal keystone species that colonizes the mucus layer and plays a direct role in maintaining the intestinal barrier and regulating metabolic health through the Amuc_1100 protein.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. In which clinical scenario is FMT currently the "Gold Standard" of care with over 90% efficacy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">Recurrent Clostridioides difficile infection (rCDI) that has failed to respond to standard antibiotic treatments.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>MRT is Ecosystem Restoration:</strong> It moves beyond individual strains to restore the functional diversity of the entire gut community.</li>
                <li><strong>Akkermansia is the Metabolic Keystone:</strong> Its presence is a primary marker for gut barrier integrity and metabolic resilience.</li>
                <li><strong>Safety First:</strong> FMT is a medical procedure with significant pathogen risks if not performed in a regulated clinical setting.</li>
                <li><strong>Postbiotics for Sensitivity:</strong> Inanimate microbial components offer a safer alternative for immunocompromised or highly reactive clients.</li>
                <li><strong>The Coach's Role:</strong> We are the "gardeners" who prepare the soil and maintain the landscape, while the "transplanting" is left to medical specialists.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Van Nood, E., et al. (2013). "Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile." <i>New England Journal of Medicine</i>.</li>
                <li>Cani, P. D., et al. (2022). "Akkermansia muciniphila: from discovery to therapeutic applications in the context of obesity and diabetes." <i>Nature Reviews Endocrinology</i>.</li>
                <li>Sokol, H., et al. (2008). "Faecalibacterium prausnitzii is an anti-inflammatory bacterium lacking in Crohn disease patients." <i>PNAS</i>.</li>
                <li>Salminen, S., et al. (2021). "The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics." <i>Nature Reviews Gastroenterology & Hepatology</i>.</li>
                <li>Khoruts, A., & Sadowsky, M. J. (2016). "Understanding the mechanisms of therapeutic fecal microflora transfer." <i>Trends in Microbiology</i>.</li>
                <li>Vrieze, A., et al. (2012). "Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome." <i>Gastroenterology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Gut Health & Microbiome Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Professional Certification Content.</p>
        </footer>
    </div>
</body>

</html>